In antibody responses, mutated germinal center B (B _GC ) cells are positively selected for reentry or differentiation. As the products from GCs, memory B cells and antibody-secreting cells (ASCs) support high-affinity and long-lasting immunity. Positive selection of B _GC cells is controlled by signals received through the B cell receptor (BCR) and follicular helper T (T _FH ) cell–derived signals, in particular costimulation through CD40. Here, we demonstrate that the T _FH cell effector cytokine interleukin-21 (IL-21) joins BCR and CD40 in supporting B _GC selection and reveal that strong IL-21 signaling prioritizes ASC differentiation in vivo. B _GC cells, compared with non-B _GC cells, show significantly reduced IL-21 binding and attenuated signaling, which is mediated by low cellular heparan sulfate (HS) sulfation. Mechanistically, N-deacetylase and N-sulfotransferase 1 (Ndst1)–mediated N-sulfation of HS in B cells promotes IL-21 binding and signal strength. Ndst1 is down-regulated in B _GC cells and up-regulated in ASC precursors, suggesting selective desensitization to IL-21 in B _GC cells. Thus, specialized biochemical regulation of IL-21 bioavailability and signal strength sets a balance between the stringency and efficiency of GC selection.

An efficient I₂/CuCl₂-promoted one-pot three-component strategy for the construction of 1,2,3-thiadiazoles from aliphatic- or aromatic-substituted methyl ketones, p-toluenesulfonyl hydrazide, and potassium thiocyanate has been developed.